SCI Abstract

search
Racial and Ethnic Disparities in Stroke Incidence and Outcomes
Racial and Ethnic Disparities in Stroke Incidence and Outcomes
Rates of stroke in the United States either continue to decline or appear to have plateaued over time. However, due to cha...
Lipoprotein(a)—Investigating Sex-Based Differences Across the Lifespan in Men and Women
Lipoprotein(a)—Investigating Sex-Based Differences Across the Lifespan in Men and Women
In this review, we summarize sex-based variations in Lipoprotein (a) [Lp(a)] levels, describe their influence on ...
Addressing Disparities in the Screening and Treatment of Dyslipidemia – A Call to Action
Addressing Disparities in the Screening and Treatment of Dyslipidemia – A Call to Action
In this review, we discuss the prevalence and reasons for such disparities, as well as the social determinants of health t...
Triple Agonism Based Therapies for Obesity
Triple Agonism Based Therapies for Obesity
Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) have transformed obesity and type 2 diabetes (T2D) management. Tirz...
Leadless Pacemakers: A Contemporary Review
Leadless Pacemakers: A Contemporary Review
Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2...
Avoiding Non-Traditional Ablation Risks with Pulse-Field Ablation for Atrial Fibrillation
Avoiding Non-Traditional Ablation Risks with Pulse-Field Ablation for Atrial Fibrillation
Not applicable. Pulsed field ablation (PFA) has been increasingly adopted for catheter ablation of atrial fibrillation, ow...
Cardiac Toxicities of Cancer Therapies: From Traditional Agents to Emerging Targets in Cardio-Oncology
Cardiac Toxicities of Cancer Therapies: From Traditional Agents to Emerging Targets in Cardio-Oncology
This review focuses on the cardiovascular toxicities linked to both traditional chemotherapy and newer targeted cancer the...
Thromboembolism Risk Management in Cardiac Amyloidosis and Atrial Fibrillation
Thromboembolism Risk Management in Cardiac Amyloidosis and Atrial Fibrillation
This review discusses the epidemiology and mechanisms of atrial fibrillation (AF) in cardiac amyloidosis (CA), the limitat...
Is Idiopathic Ventricular Tachycardia a Misnomer?
Is Idiopathic Ventricular Tachycardia a Misnomer?
To evaluate whether “idiopathic ventricular tachycardia” remains an appropriate label in the modern era. We sy...
Artificial Intelligence Across the Continuum of Atrial Fibrillation Screening, Diagnosis, and Treatment
Artificial Intelligence Across the Continuum of Atrial Fibrillation Screening, Diagnosis, and Treatment
The review aims to help clinicians understand the current landscape of artificial intelligence (AI) tools for atrial fibri...
App-Timizing Cardiac Rehabilitation: Enhancing Patient Engagement with Mobile Health Applications
App-Timizing Cardiac Rehabilitation: Enhancing Patient Engagement with Mobile Health Applications
This manuscript examines how mobile health (mHealth) applications (apps) can enhance patient engagement in cardiac rehabil...
Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions
Hypertension Management to Reduce Racial/Ethnic Disparities: Clinical and Community-Based Interventions
Hypertension remains a major public health concern globally and in the United States with significant racial/ethnic dispar...
Physical Activity Barriers, Facilitators, and Preferences in Rural Adults with Obesity
Physical Activity Barriers, Facilitators, and Preferences in Rural Adults with Obesity
To identify physical activity-related barriers, facilitators, and preferences among adults with obesity living in rural ar...
Mitral Valve Dysplasia: An Updated Review
Mitral Valve Dysplasia: An Updated Review
The purpose of this manuscript is to provide a comprehensive review for the clinician regarding the epidemiology, pathophy...
Understanding the Significance and Approach to Ventricular Tachycardia Ablation of Scar-related Border Zones
Understanding the Significance and Approach to Ventricular Tachycardia Ablation of Scar-related Border Zones
Ventricular arrhythmias in non-ischemic cardiomyopathies can be uniquely challenging to manage with a higher rate of unsuc...
Diagnosis, Evaluation, and Management of Severe Hypertriglyceridemia
Diagnosis, Evaluation, and Management of Severe Hypertriglyceridemia
Hypertriglyceridemia is known to be associated with the development of atherosclerotic cardiovascular disease (ASCVD). Sev...
Current Clinical Trials for Treating Elevated Lipoprotein(a)
Current Clinical Trials for Treating Elevated Lipoprotein(a)
Numerous studies have established lipoprotein(a) [Lp(a)] as an independent and modifiable risk factor for atherosclerotic ...
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Lipoprotein(a) [Lp(a)], an atherogenic low-density lipoprotein cholesterol (LDL-C)-like molecule, has emerged as an import...
Management of Dyslipidemia in Chronic Kidney Disease
Management of Dyslipidemia in Chronic Kidney Disease
Chronic kidney disease (CKD) ranks among the top five causes of global mortality, affecting 1 in 7 US adults (approximatel...
The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management
The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management
Obesity pharmacotherapy is rapidly evolving with the ability of glucagon-like peptide- 1 receptor agonists (GLP-1RAs) to i...
Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease
Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease
This review examines the role of lipid-lowering therapy (LLT) in the context of primary prevention of atherosclerotic card...
Clinical Update on the Intersection of Lipoprotein(a) and Calcific Valve Disease
Clinical Update on the Intersection of Lipoprotein(a) and Calcific Valve Disease
To critically review the literature and summarize the available evidence to better understand the association of Lipoprote...
Reducing Air Pollution and CV Disparities by Greenification in Urban Environments– A Path Forward
Reducing Air Pollution and CV Disparities by Greenification in Urban Environments– A Path Forward
This review article outlines the racial disparities in air pollution that contribute to the cardiovascular disease morbidi...
Artificial Intelligence for Risk Assessment on Primary Prevention of Coronary Artery Disease
Artificial Intelligence for Risk Assessment on Primary Prevention of Coronary Artery Disease
Coronary artery disease (CAD) is a common and etiologically complex disease worldwide. Current guidelines for primary prev...
Social and Demographic Correlates of Fast Food Consumption: A Review of Recent Findings in the United States and Worldwide
Social and Demographic Correlates of Fast Food Consumption: A Review of Recent Findings in the United States and Worldwide
To describe the social, demographic, and health correlates of fast food (FF) consumption. There does not appear to be a co...
Leveraging Digital Health to Improve the Cardiovascular Health of Women
Leveraging Digital Health to Improve the Cardiovascular Health of Women
In this review, we present a comprehensive discussion on the population-level implications of digital health interventions...
Genetic Contributions to Risk of Adverse Pregnancy Outcomes
Genetic Contributions to Risk of Adverse Pregnancy Outcomes
Adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy (HDP), low birthweight (LBW), and preterm...
Remote Monitoring in Cardiovascular Diseases
Remote Monitoring in Cardiovascular Diseases
The purpose of this review is to discuss and explore selected clinically integrated and commercially available devices, th...